4//SEC Filing
Granowitz Craig B 4
Accession 0001127602-24-007618
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:28 PM ET
Size
12.2 KB
Accession
0001127602-24-007618
Insider Transaction Report
Form 4
Granowitz Craig B
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+27,916→ 43,101 total - Exercise/Conversion
Common Stock
2024-02-28+35,790→ 78,891 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−31,265$81,914→ 47,626 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−27,916→ 27,917 total→ Common Stock (27,916 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−35,790→ 71,580 total→ Common Stock (35,790 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001876655
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:28 PM ET
- Size
- 12.2 KB